在未合并其他疾病的高血压患者中,添加一种低剂量降压方案可显著改善高血压的控制,并降低心血管发病率。

Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.

机构信息

National Institute for Health and Welfare, Department of Chronic Disease Prevention, Turku/Helsinki, Finland.

出版信息

Eur J Prev Cardiol. 2012 Aug;19(4):712-22. doi: 10.1177/1741826711410835. Epub 2011 May 24.

Abstract

AIMS

To assess the utilization of antihypertensive drugs among uncomplicated hypertensive patients in Finland between 2000 and 2006 and to calculate the achievable reduction in cardiovascular morbidity, with intensified antihypertensive treatment.

METHODS

From the databases of the Social Insurance Institution of Finland, 428,986 treated hypertensives without diabetes or cardiac disease (further named uncomplicated hypertensives) in 2000 and 591,206 in 2006, respectively, were identified. In addition, from the Health 2000 survey representing the whole Finnish adult population, 729 uncomplicated hypertensives were determined to assess their characteristics and control of hypertension. Applying Law's meta-analyses we calculated the reduction of blood pressure (BP) by intensifying the treatment with low-dose antihypertensive regimens for those with a BP ≥140/90 mmHg.

RESULTS

The nationwide data suggests a relative overuse of beta-blockers. Combination antihypertensive treatment increased relatively 8%, while at least three drug combinations increased from 19.8% to 21.6% between 2000 and 2006. However, calculated prevalence of controlled BP (<140/90 mmHg) increased only from 30.3% to 33.9%. Addition of one half standard dose or one to two half standard doses for the treatment of the patients with a BP ≥140/90 mmHg would improve the control of hypertension from 33.9% to 47.8% and 67.3%, respectively. The intensified treatment would reduce strokes by 18% and 28%, and ischaemic heart disease events by 13% and 21%, respectively.

CONCLUSIONS

Underutilization of preferred drugs and poor control of BP continues. Surprisingly small addition of the number of low-dose antihypertensive regimen is needed in order to substantially improve the control of hypertension and to decrease cardiovascular morbidity among uncomplicated hypertensive patients.

摘要

目的

评估 2000 年至 2006 年间芬兰单纯高血压患者的抗高血压药物使用情况,并计算强化降压治疗可降低心血管发病率。

方法

从芬兰社会保险机构的数据库中,分别确定了 2000 年和 2006 年无糖尿病或心脏病的 428986 例治疗高血压患者(进一步命名为单纯高血压患者)和 591206 例患者。此外,从代表芬兰全体成年人口的健康 2000 调查中,确定了 729 例单纯高血压患者,以评估他们的特征和高血压控制情况。应用 Law 的荟萃分析,我们通过强化治疗那些血压≥140/90mmHg 的低剂量降压方案,计算血压降低情况。

结果

全国范围内的数据表明β受体阻滞剂的使用相对过度。联合抗高血压治疗相对增加了 8%,而至少三联抗高血压治疗在 2000 年至 2006 年间从 19.8%增加到 21.6%。然而,计算出的血压控制率(<140/90mmHg)仅从 30.3%增加到 33.9%。对于血压≥140/90mmHg 的患者,增加半标准剂量或一至两个半标准剂量的一种药物治疗,将使高血压控制率分别提高到 47.8%和 67.3%。强化治疗将使卒中减少 18%和 28%,缺血性心脏病事件减少 13%和 21%。

结论

未充分利用首选药物,血压控制不佳的情况仍然存在。令人惊讶的是,只需要增加少量的低剂量降压方案,就可以大大提高单纯高血压患者的血压控制率,并降低心血管发病率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索